Does RELUGOLIX Cause Lung neoplasm malignant? 10 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Lung neoplasm malignant have been filed in association with RELUGOLIX (Orgovyx). This represents 0.1% of all adverse event reports for RELUGOLIX.
10
Reports of Lung neoplasm malignant with RELUGOLIX
0.1%
of all RELUGOLIX reports
3
Deaths
5
Hospitalizations
How Dangerous Is Lung neoplasm malignant From RELUGOLIX?
Of the 10 reports, 3 (30.0%) resulted in death, 5 (50.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which RELUGOLIX Alternatives Have Lower Lung neoplasm malignant Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM